Takeda bets $100M upfront on AC Immune's anti-amyloid Alzheimer's vaccine
AC Immune has lined up its third pharma partner in Alzheimer’s disease, and the pact comes with a hefty biobucks package.
Takeda will pay AC …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
